Human naturally occurring and adaptive regulatory T cells secrete high levels of leukaemia inhibitory factor upon activation.
Leukaemia inhibitory factor (LIF) is a member of the IL-6 cytokine family which signals through cognate receptors and activates target genes involved in survival, apoptosis, proliferation, differentiation and suppression of differentiation in different cell types. Binding of LIF to the LIFRalpha/gp130 receptor complex has been shown to activate the Janus kinase-signal transducer and activator of transcription 3 pathway. Here we show that activation of naturally occurring and adaptive regulatory T cells leads to increased LIF expression which is abrogated by cyclic adenosine monophosphate. Furthermore, the LIF receptors gp130 and LIFRalpha are upregulated on the surface of activated T cells and signal transducer and activator of transcription 3 phosphorylation is increased. Interestingly, LIF was not required for suppressive function but rather appeared to have a stimulatory effect on T cells that served to modulate and counteract immunosuppression by regulatory T cells.
Mahic
M
M
Biotechnology Centre and Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway.
Kalland
M E
ME
Aandahl
E M
EM
Torgersen
K M
KM
Taskén
K
K
D049109:Cell Proliferation; D002478:Cells, Cultured; D018920:Coculture Techniques; D050822:Cytokine Receptor gp130 / Q000378:metabolism; D005434:Flow Cytometry; D006801:Humans; D053605:Leukemia Inhibitory Factor / Q000378:metabolism*; D053680:Leukemia Inhibitory Factor Receptor alpha Subunit / Q000378:metabolism; D008213:Lymphocyte Activation / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism*
C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D053680:Leukemia Inhibitory Factor Receptor alpha Subunit; D050822:Cytokine Receptor gp130